This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pure Tech Lyt 100, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael C Chen: Innovator in Pulmonary Fibrosis Treatment
Introduction
Michael C Chen is a notable inventor based in Norwood, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of idiopathic pulmonary fibrosis (IPF). His innovative approach has the potential to improve the lives of many patients suffering from this challenging condition.
Latest Patents
Michael C Chen holds a patent for "Methods of treating idiopathic pulmonary fibrosis with deupirfenidone." This patent discloses a method of treating IPF by administering deuterium-enriched pirfenidone, known as LYT-100, at a total daily dose ranging from about 1650 mg to about 2500 mg. This advancement represents a promising step forward in the management of IPF.
Career Highlights
Chen is associated with Pure Tech Lyt 100, Inc., where he continues to work on innovative solutions for pulmonary diseases. His dedication to research and development has positioned him as a key figure in the medical community.
Collaborations
Michael collaborates with talented professionals in his field, including Paul Andrew Ford and Heather A Paden. These partnerships enhance the research and development efforts at Pure Tech Lyt 100, Inc.
Conclusion
Michael C Chen's work in developing treatments for idiopathic pulmonary fibrosis showcases his commitment to innovation in medicine. His contributions are paving the way for better therapeutic options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile